While soluble NEP (sNEP) and NEP activity have been examined in HF patients before [36, 37], we reveal for the first time NEP activity profiling after Sacubitril/Valsartan treatment in a pre-HFpEF population. This evidence concerns the gene MME and hydrops fetalis.